coin-img-BTCBTC-2.83%coin-img-SOLSOL-2.10%coin-img-USDCUSDC+0.00%coin-img-XRPXRP-2.32%coin-img-UBOXUBOX-19.45%coin-img-HYPEHYPE-5.47%coin-img-ULTIMAULTIMA+0.46%coin-img-ETHETH-2.96%coin-img-BTCBTC-2.83%coin-img-SOLSOL-2.10%coin-img-USDCUSDC+0.00%coin-img-XRPXRP-2.32%coin-img-UBOXUBOX-19.45%coin-img-HYPEHYPE-5.47%coin-img-ULTIMAULTIMA+0.46%coin-img-ETHETH-2.96%coin-img-BTCBTC-2.83%coin-img-SOLSOL-2.10%coin-img-USDCUSDC+0.00%coin-img-XRPXRP-2.32%coin-img-UBOXUBOX-19.45%coin-img-HYPEHYPE-5.47%coin-img-ULTIMAULTIMA+0.46%coin-img-ETHETH-2.96%coin-img-BTCBTC-2.83%coin-img-SOLSOL-2.10%coin-img-USDCUSDC+0.00%coin-img-XRPXRP-2.32%coin-img-UBOXUBOX-19.45%coin-img-HYPEHYPE-5.47%coin-img-ULTIMAULTIMA+0.46%coin-img-ETHETH-2.96%
user-avatar
The Manila Times

Waldencast completes sale of Obagi Medical to Bridgepoint in deal valued at up to $460 million

AI Market Summary
Waldencast completed the sale of its Obagi Medical unit to Bridgepoint for consideration up to $460m, using proceeds to repay its senior term loan and refocus on expanding Milk Makeup globally. The transaction is a company-specific balance sheet and portfolio repositioning catalyst, potentially improving leverage metrics and sharpening the equity narrative, but it is unlikely to have broader cross-asset market implications.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT-1.41%
AI Insight · NCCOGOLD2USD/USDTAI Insight
● Neutral
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Waldencast plc (NASDAQ: WALD) said it has completed the sale of its Obagi Medical dermatological skincare and aesthetics business to Bridgepoint in a transaction valued at up to $460 million, subject to negotiated deductions and customary adjustments. The company said the move is intended to strengthen its balance sheet and sharpen its strategic focus on accelerating the global growth of Milk Makeup. The transaction is positioned as a company-level divestiture catalyst that could affect expectations for WALD’s fundamentals and valuation.
Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.
Stocks

Risk Warning

Cryptocurrencies and their derivatives are innovative financial products with great volatility and high investment risks.

Although BingX is committed to providing users with easy-to-use trading tools, trading itself is still a highly sophisticated field. Trading digital assets and their derivatives are subject to high market risk and price volatility and may result in partial or total loss of account funds. You must carefully consider and exercise clear judgment to evaluate your financial situation and the aforementioned risks before using BingX Services. You shall be responsible for all losses arising therefrom. If necessary, please consult relevant professionals to make informed decisions before investing. By accessing, downloading, using or clicking on "I agree" to accept any BingX Services provided by BingX, you agree that you have read, understood and accepted all of the terms and conditions stipulated in BingX Terms of Use as well as our Privacy Policy.


Trading by copying or replicating the trades of other traders involves a high level of risks, even when copying or replicating the top-performing traders. Past performance of a BingX community member is not a reliable indicator of his future performance. Content on BingX's trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of BingX.